LATHAM, N.Y. (AP) — LATHAM, N.Y. (AP) — AngioDynamics Inc. (ANGO) on Wednesday reported a loss of $4.4 million in its fiscal third quarter.
On a per-share basis, the Latham, New York-based company said it had a loss of 11 cents. Earnings, adjusted for one-time gains and costs, came to 3 cents per share.
The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 13 cents per share.
The medical device maker posted revenue of $72 million in the period, also beating Street forecasts. Three analysts surveyed by Zacks expected $70.6 million.
AngioDynamics expects full-year results to range from a loss of 34 cents per share to a loss of 31 cents per share, with revenue in the range of $285 million to $288 million.
AngioDynamics shares have increased 5.5% since the beginning of the year. The stock has climbed 66% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ANGO at https://www.zacks.com/ap/ANGO
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
